Target intelligence / Profile preview

Neuropeptide Y messenger RNA (NPY mRNA)

Target
NPY mRNA
Molecular classification
Nucleic acid, Messenger RNA
01

Overview

Neuropeptide Y (NPY) messenger RNA (mRNA) is the genetic template for the synthesis of Neuropeptide Y, one of the most abundant and potent orexigenic (appetite-stimulating) peptides in the mammalian brain (Tatemoto et al., 1982). Primarily synthesized in the arcuate nucleus of the hypothalamus, NPY mRNA levels are highly responsive to energy status, increasing during fasting to promote food seeking and energy conservation (Stephens et al., 1995). Beyond its role in metabolism, NPY is a key regulator of the stress response, circadian rhythms, and cardiovascular function (Heilig, 2004). As a therapeutic target, NPY mRNA is approached using nucleic acid-based technologies such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) to downregulate NPY production in specific brain regions (Akabayashi et al., 1994). This approach is being explored for the treatment of obesity and metabolic disorders where NPY is overexpressed. However, the widespread physiological roles of NPY and the difficulty of delivering large, charged molecules across the blood-brain barrier present significant hurdles for clinical development (Wahlestedt et al., 1993).

Other names
Neuropeptide Y transcriptNPY mRNAPreproneuropeptide Y mRNA
02

Mechanism of action

Antisense oligonucleotides or siRNA molecules bind to the NPY mRNA sequence, leading to its degradation via RNase H or the RISC complex, thereby preventing the translation of the NPY peptide (Wahlestedt et al., 1993; Akabayashi et al., 1994).

03

Biological functions

Appetite stimulationEnergy homeostasisRegulation of blood pressureStress and anxiety modulationSeizure threshold regulationCircadian rhythm regulation
04

Disease associations

ObesityMetabolic syndromeAnxietyDepressionEpilepsyHypertension
05

Safety considerations

Blood-brain barrier penetrationOff-target gene silencingPotential for severe metabolic side effectsInflammatory response to nucleic acidsRisk of increased anxiety or lowered seizure threshold due to NPY depletion
06

Interacting drugs

Antisense oligonucleotides (experimental)

1 more in the full profile.

07

Biomarkers

NPY mRNA expression levelsHypothalamic NPY protein levelsCerebrospinal fluid NPY levels

Beyond the preview

Go deeper on Neuropeptide Y messenger RNA (NPY mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuropeptide Y messenger RNA (NPY mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call